MedTrace Logo

MPV as a Predictor for ACS in Patients With MASLD

NCT07487571 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-05-06

No results posted yet for this study

Summary

The aim of this study is to evaluate mean platelet volume (MPV) as a predictor of acute coronary syndrome (ACS) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD to evaluate mean platelet volume (MPV) as a predictor of acute coronary syndrome (ACS) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Sohag University Hospital.

Conditions

  • Metabolic Dysfunction-Associated Steatotic Liver Disease
  • Acute Coronary Syndromes (ACS)

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Usama Ahmed Arafa, MD · unaffillated

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-05
Primary Completion
2026-11-01
Completion
2026-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07487571 on ClinicalTrials.gov